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Genetic background and clinical picture of mood disorders (MD) are complex and may depend on many genes and their potential 
interactions as well as environmental factors. Therefore, clinical variations, or endophenotypes, were suggested for association studies. 
The aim of the study was to investigate association between the chronotype (CH) and quality of sleep characteristics with polymorphisms 
CLOCK, ARNTL, TIMELESS and PER3 genes in MD. We included a total sample of 111 inpatients and 126 healthy controls. To assess CH we 
applied Morningness-Eveningness Questionnaire (MEQ). Additionally, we defined the quality and patterns of sleep using The Pittsburgh 
Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS). We applied Kruskal-Wallis test to determine associations. The main positive 
findings refer to associations between selected polymorphisms and:
1) chronotype with the ARNTL gene (rs11824092 and rs1481892) and the CLOCK (rs1268271),
2) sleep duration with the CLOCK gene (rs3805148) and the TIM gene (rs2291739),
3) daytime dysfunction with the PER3 gene (rs228727, rs228642, rs10864315),
4) subjective sleep quality with the ARNTL gene (rs11824092, rs1982350),
5) sleep disturbances with the ARNTL gene (rs11600996).
We also found the significant epistatic interactions between polymorphism of the PER3 gene (rs2640909) & the CLOCK gene (rs11932595) 
and following sleep quality variables: sleep duration, habitual sleep efficiency and subjective sleep quality.
The present study suggests a putative role of the analyzed clock genes polymorphisms in chronotype in the control group and in sleep 
quality disturbances in the course of MD. The results indicate that PSQI variables can be used to refine phenotype in association studies 
of clock genes in MD.
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INTRODUCTION
Objectives
Genetic background and clinical picture of mood 
disorders (MD) are complex and may depend on many genes 
and their potential interactions as well as environmental 
factors. Therefore, clinical variations, or endophenotypes, 
were suggested for association studies.
The human biological clock determines synchronization 
of light-dark rhythm with physiological and mental 
processes (Lemoine et al. 2013, Frank et al. 2008, Ohayon 
2007a). Chronotype (CH) is an expression of individual 
circadian rhythm differences, defining the preference of 
morning (lark) or evening (owl) activity (Pracki et al. 2014). 
CH is considered as the combination of both biological 
(genetic factors, aging of the body) and psychosocial (hours 
of study or work, the rhythm of family life) processes 
(Allebrandt and Roenneberg 2008). CH is highly heritable 
(heritability ~50%) (Koskenvuo et al. 2007, von Schantz 
et al. 2015). Studies suggested relationships between CH 
and both differences in the activation level (extraversion/
introversion, novelty seeking, mobility, strength of 
activation/inhibition of the nervous system) and severity 
of depression and anxiety (Frank et al. 2013, Hasler et al. 
2013, Ottoni et al. 2012). As the result, CH may be considered © 2
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as a potential phenotype in association studies of “clock 
genes” in MD.
Sleep disturbances are common in patients diagnosed 
with MD. The prevalence of insomnia or excessive sleepiness 
during course of MD suggested a pivotal role of the circadian 
system in the development of this disorder ( Frank et al. 2008, 
Ohayon 2007b). If confirmed, treatment of sleep disorders 
should be parallel with pharmacotherapy as a part of new 
therapeutic approach (Bellivier et al. 2015). New approach 
may result in faster remission and reduce risk for suicide 
attempts (Franzen and Buysse 2008). The master biological 
clock is located in the suprachiasmatic nuclei of the anterior 
hypothalamus and is crucial for the organization of the 
circadian rhythms. The group of genes known as “clock 
genes” is responsible for the maintenance of circadian 
rhythm on the subcellular level (Tardito et al. 2010). 
Several studies documented that seasonality of mood is 
connected with seasonal exposure to light (Geoffroy et al. 
2015, Patten et al. 2016, Savides et al. 1986). Thus we expect 
that season of fulfilling self-assessment questionnaire may 
involve on giving answers.
The aim of current study is to investigate genetic 
associations between preferences of daily activity, 
characteristics of sleep quality and polymorphisms of 
pivotal “clock genes” in Polish, MD cohort.
METHODS
Participants
We included total number of 111 inpatients, who met 
DSM-IV criteria for MD in the course of bipolar (70 BPD) 
and unipolar disorder (41 UPD). The lifetime diagnosis was 
established using SCID-I (Structured Clinical Interview 
for Axis I clinical disorders for DSM-IV) (First et al. 2007). 
We applied the OPCRIT Checklist to determine lifetime 
perspective of MD and sleep disturbances symptoms. 
Our sample consisted of predominantly female (76 
female, 35 male), adults aged 18–78 years (mean=42, 
SD±17). The age of onset (mean=30, SD±12) and duration 
of disease (mean=12, SD±12) were determined based on 
the first episode meeting the DSM-IV criteria evaluated 
by a psychiatrist. We recruited patients in the hospital 
by the Department of Psychiatry, University of Medical 
Sciences in Poznan.
The control group (CG) consisted of 126 healthy 
volunteers (66 female, 60 male), aged 22–83 years 
(mean=39 years, SD±12). Control volunteers subjects were 
assessed using the Polish version of M.I.N.I screen (Mini 
International Neuropsychiatric Interview). M.I.N.I screen 
is compatible with ICD-10 and DSM-IV criteria. It allows for 
exclusion 14 disorders on I axis such as: major depressive 
disorder, dysthymia, manic symptoms, panic disorder, 
agoraphobia, social phobia, obsessive-compulsive disorder, 
post-traumatic stress disorder, alcohol abuse/dependence, 
drugs abuse/dependence, psychotic symptoms, anorexia 
& bulimia nervosa and generalized anxiety disorder 
(Lecrubier et al. 1997). The exclusion criteria from the 
control group were as follows: sleep problems (difficulty in 
falling asleep, waking up in the middle of the night, waking 
up early or too long sleep) identified in M.I.N.I. screen 
as well as more than 14 points obtained in the Epworth 
Sleepiness Scale (ESS).
Patients fulfilled self-questionnaires during 
hospitalization after obtaining euthymic state 
evaluated by psychiatrist. To standardize the interval of 
retrospective studies, patients were asked to give answers 
describing the period of remission before the current/
last episode. The study was approved by the Ethics 
Committee, University of Medical Sciences in Poznan. All 
study participants were Caucasians of Polish origin and 
gave the written, informed consent.
Questionnaires
Morningness-Evenigness Questionnaires (MEQ)
We assessed chrontype using Polish, validated 
adaptation of Morningness-Evenigness Questionnaires 
previously used by (Ciarkowska in unpublished 
results) Circadian Activity Rhythm Questionnaire – 
standardisation on Polish population (N=12080) MEQ 
(Morningness-Evenigness Questionnaires) (Horne and 
Ostberg 1976). The questionnaire consisted of 21 questions 
that cover basis of subjective personal observations, 
behavior, experiences, senses etc. Resulting data was used 
to assess individual chronotype (morning, moderate/
neutral and evening) was assessed following suggestions 
by (Pracki et al. 2014). 
The Pittsburgh Sleep Quality Index (PSQI)
We applied The Pittsburgh Sleep Quality Index (PSQI) 
to assess the quality and patterns of sleep in adults. The 
PSQI consists of 19 questions covering: subjective sleep 
quality, sleep latency (the time it takes to fall asleep), 
sleep duration, habitual sleep efficiency (the ratio of total 
sleep time to time in bed), sleep disturbances, the use 
of sleep-promoting medication (prescribed or over-the-
counter), and daytime dysfunction. Each item is scored 
from minimum of 0 (better) to maximum of 3 (worse). 
The seven component scores may be summed to provide 
a global score (PSQI), with higher scores reflecting 
poorer sleep quality. A score of ≥5 on the global rating 
suggests moderate sleep problems in ≥3 areas, or more 
severe problems in at least two areas (Buysse et al. 1989).
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Epworth Sleepiness Scale (ESS)
We assessed the likelihood of falling asleep due to 
excessive sleepiness using Epworth Sleepiness Scale 
(ESS), one of the most common scales in sleep medicine. 
The participant is asked to assess, on a scale of 0–3, the 
probability of falling asleep in eight typical situations from 
everyday life. Number of points below 10 indicates a lack of 
excessive sleepiness; score above 14 indicates pathological 
sleepiness (Johns 1991).
Clinical variables from OPCRIT
OPCRIT provides a convenient, reliable, rapid and valid 
approach to polydiagnostic assessment with consensus 
best-estimate lifetime diagnoses. It provides a synthesis of 
the SCID interview. In its basis we chose the demographic 
data (age, gender, age of onset); variables related to sleep 
problems (reduced need for sleep, initial insomnia, middle 
insomnia (broken sleep), early morning waking and 
excessive sleep) and course of disorder in lifetime, which 
can be omitted in the self-assessment questionnaires 
provided according to the last period of remission 
(Craddock et al. 1996).
Genotyping
Blood [10 ml collected in a vacuum tube with anti-
coagulant ethylenediaminetetraacetic acid (EDTA)] 
samples were obtained from each participants. Genomic 
DNA was extracted from collected blood using the Miller’s 
salting-out method (Miller et al. 1988). We select candidate 
genes according to review of literature. The SNP in genes 
were chosen according to tag SNP selection in Haploview 
v 4.2 (Barrett et al. 2005) using HapMap (International 
HapMap 2003, Zhang et al. 2015) database for Caucasian 
population and supplemented by SNPs previously 
reported associations for psychiatric disorders. Analyzed 
polymorphisms are as follows: 9 polymorphisms of CLOCK 
gene (rs1801260, rs3805148, rs6849474, rs11932595, 
rs12648271, rs6850524, rs12649507, rs4340844, rs534654), 
18 polymorphisms of ARNTL gene (rs1481892, rs4146388, 
rs10766075, rs4757142, rs7396943, rs11824092, rs7947951, 
rs7937060, rs1562438, rs3816360, rs7126303, rs3789327, 
rs11022778, rs11600996, rs11022779, rs11022780, 
rs7107287, rs1982350), 6 polymorphisms of TIMELESS gene 
(rs2291739, rs2291738, rs7302060, rs10876890, rs11171856, 
rs2279665) and 9 polymorphisms of PER3 gene (rs836755, 
rs228727, rs10864315, rs4908694, rs228682, rs228642, 
rs2172563, rs2640909, rs10462021). Detailed description of 
protocol and analyzed polymorphisms and are presented 
in previous references (Dmitrzak-Weglarz et al. 2015, 
Maciukiewicz et al. 2014). TaqMan SNP (single nucleotide 
polymorphism) genotyping was performed using an ABI 
Prisms 7900HT Sequence Detection System. We applied the 
allelic discrimination analysis module in SDS v 2.1 software 
(Applied Biosystems, Foster City, CA). 
Statistics
Statistical analyzes were performed at the Department 
of Computer Science and Statistics and at the Department 
of Psychiatric Genetics of Poznan University of Medical 
Sciences. 
P value of less than 0.05 was considered statistically 
significant. Categorical variables are expressed as 
percentages. Continuous data was checked for normal 
distribution by Shapiro-Wilk’s test. Variables measured on 
an ordinal scale are presented as the medians with 25th 
and 75th percentiles. Univariate analysis was performed. 
Categorical variables were analyzed by the χ2 test or Fisher-
Freeman-Halton test, when applicable. The Spearman’s 
rank correlation test is used to evaluate the associations 
between the variables measured on an ordinal scale. 
Comparisons of continuous data, which are non-normally 
distributed, are performed by using the Mann-Whitney 
U test. Comparisons of ordinal variables are analyzed by 
the Mann-Whitney U test or the Kruskal-Wallis test with 
Dunn’s multiple comparisons test. The regression models 
for additive model was performed to find association 
between genotypes and selected variables. The multifactor 
dimensionality reduction (MDR) to compute epistatic 
interaction of genes was used. For the quantitative MDR 
10,000 permutations were used as a correction method. For 
the power test the log additive mode of inheritance was 
employed. We also used R t, Statistica 10 (v 10, StatSoft, 
Krakow, Poland), and StatXact (v 8, Cytel, Cambridge, 
Massachusetts), 64 bit Statsoft software and PLINK software.
RESULTS
Chronotype
We noticed no significant differences between patients 
and controls in frequency of chronotype regardless of the 
type of disease (p>0.05) (Table I, Fig. 1).
Sleep variables
Table II presents results of comparisons between 
controls and selected group of patients. All characteristics 
were significantly worse in patients then controls (p<0.05) 
except duration of sleep with no significant differences 
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(p>0.05). We noticed difference in the sleep latency when 
compared BPD and UPD groups (p=0.0092), with higher 
values in UPD patients.
Sleep variables: chronotype and season
We were interested in whether sleep quality variables 
are dependent on chronotype or season of fulfilling the 
survey. For this purpose we have made an independent 
assessment in a control group and patients to exclude the 
impact of diagnosis on the results. 
We detected association between chronotype and 
individual components of sleep quality in neither MD 
nor controls groups (data not shown). However, in both 
groups the deteriorating of total sleep quality with 
shift chronotype towards the evening preference of 
activity was observed (CG: K-W H=8.648, p=0.0132; MD: 
K-W H=6.325, p=0.0432) (Fig. 2). Thus we can indirectly 
infer that evening chronotype is associated with poorer 
quality of sleep.
In the control group, we observed relation between 
the sleep quality and the season of fulfilling the 
questionnaire (K-W H=10.2192, p=0.0168) (Fig. 3), with 
Table I. Frequency of chronotypes in patients & controls
Evening  
chronotype
Intermediate  
chronotype
Morning  
chronotype ch2 (df=2) p value
Controls n=126 51 (40.48) 45 (35.71) 30 (23.81) –
Patients n=111 54 (48.65) 41 (36.94) 16 (14.41) 3.598 0.1655
BPD patients n=70 30 (42.86) 30 (42.86) 10 (14.28) 2.662 0.2662
UPD patients n=41 24 (58.54) 11 (26.83) 6 (14.63) 4.183 0.1235
BPD vs. UPD p=0.1758; ch2 Pearson test; % in the brackets
Fig. 1. Frequency of chronotypes in patients & controls. N – number of subjects, MD – mood disorder.
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worse quality of sleep in winter when compared to 
summer (Dunn’s test p=0.0414). This may be a result 
of overall well-being during summer and relaxation 
connected with the holiday period. This dependency is 
not found in MD patients. This means that the quality 
of sleep is the same, irrespective of the season and 
indicates a direct relationship with the disease (K-W 
H=1.5387, p=0.6733).
Correlation with clinical variables
Several items of OPCRIT describe sleep problems during 
illness episode and may be correlated with chronotype 
(Table III). We detected suggestive correlations between 
reduced need for sleep, initial insomnia and early 
morning waking with chronotype or course of disorder 
with total score of PSQI and ESS. Higher results obtained 
in total score of PSQI (rs=−0.2654) and reduced need for 
sleep (rs=−0.2319) demonstrating the poorer quality 
of sleep were associated with evening chronotype. In 
contrast, initial insomnia (rs=0.3485), early morning 
waking (rs=0.2830) and increased sleepiness during the 
day (measured by ESS) (rs=0.3800) were correlated witch 
morning chronotype.
All significant correlations (<0.05) ranged from 0.17 
to 0.38 which is a poor correlation/weak relationship, 
thus should be treated as preliminary results and need 
confirmation in further studies.
Chronotype, sleep quality variables and genes
To determine the relationship of studied genes and 
their polymorphisms with diagnosis and the preference 
of daily activity or sleep variables, analyzes were 
performed independently for groups of patients and 
control subjects. 
We conducted genetic association between genotypes 
and chronotype, sleep quality variables using Kruskal-
Wallis test. Additionally, we used regression models applied 
in PLINK to look for association between genotypes and 
selected variables. 
Significant, nominal associations were observed 
in the case of one polymorphisms of the CLOCK gene 
(rs1268271, p=0.0402) and two polymorphisms of ARNTL 
gene (rs11824092, p=0.0375, and rs1481892, p=0.0309) with 
chronotype only in control case (Table IV). 
Significant nominal association in patients group was 
observed in cases as follows:
1) sleep duration with CLOCK (rs3805148, p=0.0118) and TIM 
(rs2291739, p=0.0184),
2) daytime dysfunction with PER3 (rs228727, p=0.0465, 
rs228642, p=0.0280 and rs10864315, p=0.0161),
3) subjective sleep quality with ARNTL (rs11824092, 
p=0.0366, and rs1982350, p=0.0487),
4) sleep disturbances with ARNTL (rs11600996, p=0.0447) 
(Table V).
Fig. 2. Sleep quality difference between chronotypes in CG & MD.
Fig. 3. Sleep quality difference between seasons in CG.
3_626_Dmitrzak_Węglarz_v4.indd   36 18/04/16   21:09
Acta Neurobiol Exp 2016, 76: 32–42 Chronotype, sleep quality and genes in mood disorder  37
Epistatic interaction
During second stage of genetics analyzes, we 
employed Multifactor Dimensionality Reduction (MDR) 
for chronotype and sleep quality variables to compute 
pairwise epistatic interaction between circadian genes 
variants. 
MDR analysis did not show significant epistatic 
interactions between circadian genes variants with 
chronotype in control group as well as MD patients (data 
not showed).
Nevertheless, significant epistatic interaction 
between polymorphism rs2640909 of PER3 gene and 
rs11932595 of CLOCK gene were obtained in: sleep 
duration (p=0.0123), habitual sleep efficiency (p=0.0132) 
and subjective sleep quality (p=0.0163) in MD patients 
(Table VI). No significant interactions were observed in 
controls.
Table II. Sleep variables differences between controls and selected groups of patients
Compared groups CG vs. MD CG vs. BPD CG vs. UPD BPD vs. UPD
Sleep variables p value p value p value p value
Sleep duration  0.5232  0.7412  0.2079  0.2770
Sleep disturbances  0.0002  0.0011  0.0071  0.4819
Sleep latency  0.00001  0.0002  0.000000  0.0092
Daytime dysfunction  0.00001  0.0011  0.000079  0.0568
Habitual sleep efficiency  0.0008  0.0318  0.0002  0.4487
Subjective sleep quality  0.0002  0.0472  0.00005  0.0601
Medicine-Induced Sleep  0.000034  0.000072  0.000056  0.5953
PSQI_TOTAL  0.000000*  0.000000*  0.000002*  0.1897*
ESS-sleepiness  0.000000*  0.000000*  0.000000*  0.2790*
CG – control group, MD – mood disorders, BPD – bipolar disorder, UPD – unipolar disorder, PSQI_TOTAL – global score of sleep quality, ESS – Epworth Sleepiness Scale;  
ch2 Pearson test or Fisher-Freeman-Halton test in case <5, *Mann-Whitney test; significant p value – in bold
Table III. Correlation between chronotype, total sleep quality and sleepiness and selected variables from OPCRIT (R Spearman) – only in patients
CHRONORTYPE PSQI_TOTAL ESS
CHRONORTYPE  	 −0.2654 	 −0.1697
PSQI_TOTAL 	 −0.2654   0.3800
ESS  0.3800 	 −0.1697  
Gender  0.3139  0.0455  0.2017
Age of onset  0.0569  −0.1368  −0.1786
Reduced need for sleep 	 −0.2319  0.1603  0.0955
Initial insomnia  0.3485  −0.0163  −0.0699
Middle insomnia (broken sleep)  0.2221  0.0916  −0.1066
Early morning waking  0.2830  0.0967  −0.0867
Excessive sleep  −0.0876  −0.1334  0.1184
Course of disorder (with or without remission)  −0.0487 	 −0.2405  0.0807
PSQI_TOTAL – global score of sleep quality, ESS – Epworth Sleepiness Scale; significant correlations with p value <0.05 – in bold
3_626_Dmitrzak_Węglarz_v4.indd   37 18/04/16   21:09
38  M. Dmitrzak-Węglarz et al. Acta Neurobiol Exp 2016, 76: 32–42
Table V. Significant associations between analyzed polymorphisms and sleep quality variables in patient group
Gene SNP ID K-W H p value Genotypes, p value
Sleep Duration
CLOCK rs3805148 8.8762 0.0118
AA AC
AC 0.7567 NA
CC 0.0217 0.0124
TIM rs2291739 7.9894 0.0184
CC CG
CG 0.0224 NA
GG 0.5760 0.0224
Daytime Dysfunction PER3
rs228727 6.1370 0.0465
CC CT
CT 0.6952 NA
TT 0.3368 0.0363
rs228642 7.1528 0.0280
AA AT
AT 0.0218 NA
TT 0.2095 0.6554
rs10864315 8.2581 0.0161
CC CT
CT 0.0186 NA
TT 0.1095 1.000
Subjective sleep Quality ARNTL
rs11824092 6.6149 0.0366
AA AG
AG 0.1327 NA
GG 0.0864 0.1327
rs1982350 6.0435 0.0487
CC CT
CT 0.1027 NA
TT 0.0477 0.3895
Sleep Disturbances ARNTL rs11600996 6.2145 0.0447
CC CT
CT 0.5445 NA
TT 0.4111 0.0434
Kruskal-Wallis test, significant p value – in bold
Table IV. Significant association between analyzed polymorphisms and chronotype in control group
Gene SNP ID K-W H p value Genotypes, p value
Chronotype
CLOCK rs1268271 6.4277 0.0402
CC CG
CG 0.5447 NA
GG 0.8726 0.0342
ARNTL rs11824092 6.5688 0.0375
CC CT
CT 0.6299 NA
TT 0.0601 0.0305
ARNTL rs1481892 6.9531 0.0309
CC CG
CG 0.0253 NA
GG 0.0253 0.9831
Kruskal-Wallis test, significant p value – in bold
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DISCUSSION
Chronotype
Mood disorders are associated with disrupted biological 
rhythmes and as the result with sleep disturbances. 
Chronotype allows description of individual preferred activity 
pattern. The comparison of subjective and objective method of 
daily activity preferences in a group of healthy subjects, proved 
that the use of Polish adaptation of the MEQ is a valid method 
of the chronotype assessment (Pracki et al. 2014). However, we 
failed to observe any significant differences between patients 
and controls in the frequency of chronotype regardless of the 
type of disease, probably due to small sample size. Our results 
may be due to relatively not enough numerous groups, as 
well as with the restriction applied a statistical approach. On 
the other hand, we observed the deteriorating of total sleep 
quality with shift chronotype towards the evening preference 
of activity in CG and as MD groups. This is consistent with 
previous findings and suggests we selected appropriate tool 
and research direction. 
Research provided by National FINRISK Study showed 
relations between preference for morning activity and lower 
depressive symptoms (Konttinen et al. 2014). In turn, subsample 
of outpatients with insomnia, those with morning chronotype 
showed the greatest reduction of depressive symptoms after a 
cognitive behavioral therapy (CBT) (Bei et al. 2015).
Research by Merikanto and others (2015) confirmed 
that the diurnal preference towards evening activity is 
accompanied by three or more lifetime mental disorders, 
more sleeping problems, more seasonal variation in mood and 
behaviour, and more burnout when compared with those with 
the diurnal preference towards morningness. All researches 
mentioned above suggest that evening preference may have 
distinct relationships with the deterioration of mood, while 
morning chronotype seems to be a protective factor in 
depression, as well as is associated with a better prognosis.
Sleep variables
Sleep disorders in the course of affective disorders for 
a long time have been considered as a result of circadian 
rhythm disturbances. Changes in a sleep pattern, e.g., 
changes of time or amount of sleep are associated with 
circadian rhythm. Many researchers have postulated that 
sleep disorders are the cause and/or trigger of MD. They 
also indicated that the process can proceed bidirectionally, 
which means that MD can result in disturbed sleep 
(Geoffroy et al. 2014, Frank et al. 2008). Therefore, we 
conducted a detailed analysis of quality sleep variables. We 
used a self-assessment questionnaire PSQI and ESS with 
proven utility in routine practice (Boudebesse et al. 2014).
All sleep characteristics were significantly worse 
in MD patients than controls. Only duration of sleep 
was comparable in all analyzed groups. Our results are 
consistent with those presented by Wang and others (2014) 
and Geoffroy and colegues (2014) for BPD patients, as well 
as with the results presented by Saunders and others (2015) 
for UPD patients (Geoffroy et al. 2014, Saunders et al. 2015, 
Wang et al. 2014). 
We also provided a comparison of sleep quality variables 
between BPD and UPD patients. The sleep latency was the 
only variable that significantly differentiated the BPD 
and UPD groups. The waiting time for sleep was longer in 
patients with UPD. According to our knowledge, there is no 
such comparison in the literature.
Sleep variables: chronotype and season
We investigated if sleep quality variables are dependent 
on chronotype or season of fulfilling the questionnaire 
and discovered that regardless of diagnosis the evening 
chronotype is connected with the poorer quality of sleep. 
Similar conclusions were obtained by studying the Haregu 
and others (2015) who made circadian rhythm, sleep quality 
and daytime sleepiness characteristics among Thai college 
students. The General Health Questionnaire-12 (GHQ-12) 
was used to evaluate the presence of common psychiatric 
disorders (CPDs). Using logistic regression models, they 
found a significant association between CPDs and sleep 
characteristics, such as evening chronotype, poor sleep 
quality and daytime sleepiness (Haregu et al. 2015). To our 
knowledge, so far no one has checked whether sleep quality 
variables depend on the season in which the questionnaire has 
Table VI. Significant results of MDR analyzis
PSQI SNP1_PER3 SNP_CLOCK beta H WH beta L WL Wmax Perm, P
Sleep duration rs2640909 rs11932595 2.434 7.230 –1.955 9.470 9.470 0.0123
Habitual sleep efficiency rs2640909 rs11932595 2.250 9.453 −2.250 9.453 9.453 0.0132
Subjective sleep quality rs2640909 rs11932595 1.840 4.610 −1.352 4.932 4.932 0.0163
beta H – high risk category, WH – the Wald statistics for the High risk category, beta L – low risk category, WL – the Wald statistics for the Low risk category, Wmax – the 
maximum between the two Wald statistics, Perm, P – the adjusted permutation p-value obtained from the permutation distribution of Wmax, significant p value – in bold
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been completed. As could be expected in control group sleep 
quality is better in the summer. Conversely, in patients poor 
quality of sleep is constant and independent of the season.
Correlation with clinical variables
Based on our previous studies, we selected OPCRIT items 
describing sleep problems during illness episodes such as: 
reduced need for sleep, initial insomnia, middle insomnia 
(broken sleep), early morning waking and excessive sleep 
(Maciukiewicz et al. 2014). We found no significant effect 
of gender or age of onset on chronotype or sleep quality. 
Correlations suggested significant relations between our 
chronotype (reduced need for sleep, initial insomnia, early 
morning waking) and sleep quality (course of the disease). 
We found significant correlations worthy of further analysis, 
but our results are limited by the size of the analyzed group. 
Maciukiewicz and others (2014) used sleep disturbances as 
dimension created form OPCRIT variables such as middle 
insomnia (broken sleep) and early morning walking. This 
dimension was used as a quantitative trait in computations. 
Although the approach used by Maciukiewicz was not possible 
in the present study (due to the size of the group), current results 
confirmed a direct link between the quality of sleep before a 
disease and sleep disorders in the course of the disease. We did 
not observed significant correlation between initial insomnia 
variable from OPRRIT check list and PSQI or EES variables. 
The reason for this result may be that the initial insomnia is a 
symptom heralding a relapse and does not relate to the period 
of remission described in self-assessment questionnaire.
Chronotype, sleep quality variables and genes
The present study is the first association study of 
chronotype with such a wide range of “clock genes” and 
their polymorphisms. 
The significant nominal association was observed in 
the case of 2 polymorphisms of ARNTL gene (rs11824092 
and rs1481892) and one polymorphism of the CLOCK gene 
(rs1268271) with chronotype in control case. No statistically 
significant association in MD patients was observed.
The present study suggests a putative role of the 
CLOCK and ARNTL polymorphisms in the determination 
of chronotype in control group. The lack of significant 
association with chronotype in MD patients may results from 
masking effect due to significant association of “clock gene” 
polymorphisms with MD demonstrated in earlier studies 
(Dmitrzak-Weglarz et al. 2015, Maciukiewicz et al. 2014). We 
noticed mainly effect of between variable number tandem-
repeat (VNTR) in the PERIOD3 gene (PER3, rs57875989) 
and chronotype. Previous studies suggested association 
between the longer PER3(5) allele and diurnal preference, 
while shorter PER3(4) allele is linked with preference for 
evening, respectively (Archer et al. 2003, Dijk and Archer 
2010, Ebisawa et al. 2001, Nievergelt et al. 2006, Pereira et 
al. 2005). Other study conducted on Chinese and Norwegian 
populations indicated lack of association between the PER3 
clock gene and chronotype. It suggests, that the proposed 
role of PER3 needs further clarification, especially in context 
of ethnic differences (An et al. 2014, Osland et al. 2011). 
Very few association studies of clock gene 
polymorphisms and the sleep quality variables became 
a contribution to carrying out this study. We observed 
significant nominal association only in patients group in 
cases as follows: sleep quality with ARNTL (rs11824092, 
rs1982350); sleep duration with CLOCK (rs3805148) and 
TIM (rs2291739); daytime dysfunction with PER3 (rs228727, 
rs228642, rs10864315); sleep disturbances with ARNTL 
(rs11600996).
The present study suggests that “clock genes” may be 
involved in disturbances in sleep, observed in the course of 
MD. Moreover, PSQI variables can be used to refine phenotype 
in association studies of clock genes in MD. Parsons and 
others (2014) found a significant association between 
guanine nucleotide binding protein beta 3 (GNβ3) (rs5443) 
and global sleep quality, & between a rare polymorphism 
in period homologue 2 (PER2) (rs2304672) and both sleep 
duration and quality measured by PSQI. The differences in 
our and mentioned above study may arise from:
1) different groups of subjects (MD patients in our study vs. 
healthy young adults aged 18–27),
2) different sets of tested genes and their polymorphisms 
(42 polymorphism from 4: CLOCK, ARNTL, TIMELESS and 
PER3 genes vs. 10 polymorphisms from 8: ARNTL2, CLOCK, 
DBP, PER1, PER2, PER3, FBXL3, GNβ3),
3) the results obtained in different models (additive 
models of inheritance – justified in complex diseases vs. 
recessive model).
Despite significant methodological differences in both 
studies, common denominator is that findings suggest 
that genes with circadian expression may play a role in 
regulating both the circadian clock and sleep homeostasis. 
It also highlights the importance of further studies aimed 
at dissecting the specific roles that circadian genes play 
in these two interrelated but unique behaviors in control 
group, as well as in patients with MD.
Finally, we looked for any epistatic interactions 
between circadian gene variants and chronotype, as well 
as with sleep quality variables. Rs2640909 of PER3 gene and 
rs11932595 of CLOCK gene produced a significant model 
when we searched a relation to sleep duration, habitual 
sleep efficiency and sleep quality in MD patients only. No 
significant interactions were observed in controls. The 
results again indicated the relationship of “clock gene” 
with the PSQI variables in MD patients with poor quality of 
sleep regardless of disease status.
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Limitations
A fundamental limitation of the present study is the 
analyzed sample size. While number of fulfilled surveys is 
satisfactory in relation to publications mentioned above, it 
is still too low for association studies. Therefore, we failed 
to carry out more advanced and comprehensive calculation 
methods, e.g. data mining. The lack of using objective 
methods to assessing chronotype and quality of sleep, as 
well as the number of selected polymorphisms also may be 
the limitation.
CONCLUSIONS
The present study suggests a putative role of the CLOCK 
and ARNTL polymorphisms in chronotype determination 
in control group. The lack of significant association with 
chronotype in MD patients may results from masking 
effect due to significant association of “clock gene” 
polymorphisms with MD demonstrated in earlier studies.
Obtained results confirms role of the analyzed “clock 
genes” polymorphism in sleep quality disturbances in the 
course of MD. The results indicate that PSQI variables can 
be used to refine phenotype in association studies of clock 
genes in mood disorders.
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